Postoperative Chronic Pain Clinical Trial
Official title:
Effect of Metformin on Chronic Pain After Thoracic Surgery in Diabetic Patients
Metformin has been found to have more and more functions as a commonly used hypoglycemic drug in clinic. It has been found that metformin has anti-inflammatory, anti-tumor and lipid metabolism regulating effects. Basic studies have shown that metformin as an adjuvant drug combined with gabapentin and tramadol is safe and effective in patients with neuropathic pain. Postoperative chronic pain as a common complication has seriously affected the quality of life and mood of patients after surgery.Some studies have shown that chronic pain after partial operation manifests as neuropathic pain. The effect of metformin on chronic pain after thoracic surgery in patients with diabetes mellitus was observed in this experiment, which was compared with patients taking insulin to control blood sugar.
Status | Not yet recruiting |
Enrollment | 200 |
Est. completion date | December 31, 2020 |
Est. primary completion date | December 9, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: 1. Aged between 18 and 70 2. Diabetes history. Use metformin or insulin to control blood sugar 3. The type of operation is selective thoracoscopic lobectomy. Exclusion Criteria: 1. Newly diagnosed diabetic patients at admission 2. Complication of severe cardiopulmonary diseases 3. Refuse to participate in this experiment 4. Participate in other trials 5. Patients with diabetic complications (including diabetic nephropathy, peripheral neuropathy, etc.) |
Country | Name | City | State |
---|---|---|---|
China | The Affiliated Hospital of Xuzhou Medical University | Xuzhou | Jiangsu |
Lead Sponsor | Collaborator |
---|---|
Xuzhou Medical University |
China,
Ge A, Wang S, Miao B, Yan M. Effects of metformin on the expression of AMPK and STAT3 in the spinal dorsal horn of rats with neuropathic pain. Mol Med Rep. 2018 Apr;17(4):5229-5237. doi: 10.3892/mmr.2018.8541. Epub 2018 Feb 1. — View Citation
Pecikoza UB, Tomic MA, Micov AM, Stepanovic-Petrovic RM. Metformin Synergizes With Conventional and Adjuvant Analgesic Drugs to Reduce Inflammatory Hyperalgesia in Rats. Anesth Analg. 2017 Apr;124(4):1317-1329. doi: 10.1213/ANE.0000000000001561. — View Citation
Shiers S, Pradhan G, Mwirigi J, Mejia G, Ahmad A, Kroener S, Price T. Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin. J Neurosci. 2018 Aug 15;38(33):7337-7350. doi: — View Citation
Smith B, Ang D. Metformin: Potential analgesic? Pain Med. 2015 Dec;16(12):2256-60. doi: 10.1111/pme.12816. Epub 2015 May 29. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of chronic pain after operation | A VAS score greater than or equal to 3 is defined as the presence of chronic pain after surgery. | 3 months after operation | |
Secondary | VAS score at extubation time, 12 hours and 24 hours after operation | A VAS score greater than or equal to 3 is defined as the presence of pain after surgery. | extubation time, 12 hours and 24 hours after operation | |
Secondary | Neuropathic pain score and incidence at 3 months after operation | Assessment of the presence of neuropathic pain by using self-rating scale | 3 months after operation | |
Secondary | Anxiety and Depression Score | Assessment of Anxiety and Depression in Patients by HAMD Depression Scale | 3 months after operation | |
Secondary | Length of ICU stay | Some patients may need to be transferred to ICU. | an average of 2 days | |
Secondary | Length of hospital stay | Total length of hospitalization | an average of 10 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05492669 -
Intravenous Lidocaine on Chronic Pain in Patients Undergoing Hepatectomy
|
Phase 2 |